DXR

Daxor Corporation

Insider Trades

NameValueActionPriceCurrent Price
Feldschuh Michael RichardDirector, Officer: Chief Executive Officer
$9.1k1k shares
BuyApr 8, 2026
$9.07
--
Michel Robert JChief Financial Officer
$9.9k1k shares
BuyMar 31, 2026
$9.90
--
Jefferies JohnChief Medical Officer
Disclosure amount unavailable3.7k shares
BuyMar 20, 2026
--
--
Jefferies JohnChief Medical Officer
Disclosure amount unavailable2.3k shares
BuyMar 20, 2026
--
--
Feldschuh Jonathan AdamDirector, Officer: Chief Scientific Officer
Disclosure amount unavailable18k shares
BuyDec 9, 2025
--
--
Michel Robert JChief Financial Officer
Disclosure amount unavailable3k shares
BuyDec 9, 2025
--
--

News

globenewswire.comDaxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitorglobenewswire.comJun 2globenewswire.comDaxor Leverages MedAxiom CV Transforum Spring'26 to Accelerate Commercial Adoption of Blood Volume Analysisglobenewswire.comApr 28globenewswire.comDaxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Centerglobenewswire.comApr 8globenewswire.comDaxor's Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026globenewswire.comMar 26